⚠️ Disclaimer

ARA-290 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

ARA-290 (Erythropoietin-derived tissue-protective peptide) is a Innate repair receptor agonist, anti-inflammatory peptide researched for neuropathic pain relief, inflammation reduction, nerve fiber regeneration, improved autonomic function, metabolic control in diabetes. For beginners, start at the lower end of the dosage range (2-4 mg daily) and administer once daily via subcutaneous injection.

What Is ARA-290?

ARA-290 (Erythropoietin-derived tissue-protective peptide) is a Innate repair receptor agonist, anti-inflammatory peptide. Synthetic 11-amino acid peptide engineered from the tissue-protective domain of erythropoietin (EPO).

It is researched for its potential effects on neuropathic pain relief, inflammation reduction, nerve fiber regeneration, improved autonomic function, metabolic control in diabetes. The only EPO-derived peptide that completely decouples tissue protection from red blood cell production — providing nerve regeneration without any hematologic effects.

For beginners: This guide assumes no prior peptide experience. We'll cover everything from what ARA-290 is to how to reconstitute, inject, and structure your first cycle.

How Does ARA-290 Work?

Selectively activates the innate repair receptor (IRR), a CD131/EPOR heterodimer, triggering anti-inflammatory and tissue-protective signaling without any effect on red blood cell production. Suppresses microglia activation and pro-inflammatory cytokine release. Dose-dependently reduces neuropathic pain through central inflammation suppression.

Understanding the mechanism helps set realistic expectations about what ARA-290 can and cannot do.

How Do You Get Started With ARA-290?

Step 1 — Source: Purchase ARA-290 from a vendor with third-party Certificate of Analysis (COA) testing. This confirms purity (aim for 98%+) and rules out contamination.

Step 2 — Supplies: You'll need bacteriostatic water, insulin syringes (1mL/100-unit), alcohol swabs, and a clean workspace.

Step 3 — Reconstitute: Add BAC water to the ARA-290 vial — use our peptide calculator for exact amounts. Let the water run down the side of the vial; never spray directly on the powder. Swirl gently.

Step 4 — Dose: Draw 2-4 mg daily using the calculator's syringe unit conversion.

Step 5 — Inject: Clean the injection site with alcohol. Pinch a fold of abdominal fat and insert the needle at 45° for subcutaneous injection. Push the plunger slowly and hold for 5 seconds.

Calculate Your ARA-290 Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for ARA-290.

Open Calculator →

What Should Your First ARA-290 Cycle Look Like?

Dosage: Start at the lower end of 2-4 mg daily. This lets you assess tolerance before committing to a full cycle.

Frequency: once daily via subcutaneous injection.

Duration: 28 days typical; 8-16 weeks for extended response. Don't cut cycles short — many Innate repair receptor agonist, anti-inflammatory peptide effects take weeks to fully manifest.

Off-cycle: Plan a 4-week break before starting another cycle.

What Side Effects Should Beginners Watch For?

Safe profile in multiple clinical trials. Minimal reported adverse events. Occasional mild injection site reactions. No serious safety concerns identified across diabetes, sarcoidosis, and neuropathy patient populations.

As a beginner, track everything — dose, time, injection site, and any effects (positive or negative). This data helps optimize future cycles.

What Are Common Beginner Mistakes?

Not using BAC water: Sterile water lacks the preservative that prevents bacterial growth. Always use bacteriostatic water.

Inconsistent dosing: Skipping doses or varying timing significantly reduces outcomes. Set a daily alarm.

Poor storage: Reconstituted ARA-290 must stay refrigerated at 2-8°C. Leaving it at room temperature degrades the compound rapidly.

Buying cheap: Low-cost peptides without COA testing may be underdosed, contaminated, or mislabeled. Quality matters more than price.

Bottom Line for ARA-290 Beginners

Start at the lower end of 2-4 mg daily, dose once daily, cycle for 28 days typical; 8-16 weeks for extended response, and track everything. Source from COA-tested vendors and follow proper reconstitution protocol.

Read our complete peptide beginner's guide for general peptide education beyond ARA-290.

Complete Guide

ARA-290 : Benefits, Dosage, Side Effects & Research

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research ARA-290, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse ARA-290

Limitless → Browse ARA-290

Frequently Asked Questions

What is ARA-290?

ARA-290 (Erythropoietin-derived tissue-protective peptide) is a Innate repair receptor agonist, anti-inflammatory peptide. Synthetic 11-amino acid peptide engineered from the tissue-protective domain of erythropoietin (EPO). It is researched for neuropathic pain relief, inflammation reduction, nerve fiber regeneration, improved autonomic function, metabolic control in diabetes.

What is the recommended ARA-290 dosage?

Common dosages: 2-4 mg daily administered once daily via subcutaneous injection. Cycle length: 28 days typical; 8-16 weeks for extended response. Half-life: approximately 24 hours. Use our peptide calculator for exact reconstitution math.

What are the side effects of ARA-290?

Safe profile in multiple clinical trials. Minimal reported adverse events. Occasional mild injection site reactions. No serious safety concerns identified across diabetes, sarcoidosis, and neuropathy patient populations.

Is ARA-290 safe?

ARA-290 has shown a preliminary safety profile in research. Investigational. Underwent Phase II clinical trials. Not FDA-approved. All research should follow appropriate safety protocols.